Alejandro Galindo - Jul 31, 2022 Form 4/A - Amendment Insider Report for MANNKIND CORP (MNKD)

Role
EVP Endocrine Business Unit
Signature
/s/ Alejandro Galindo
Stock symbol
MNKD
Transactions as of
Jul 31, 2022
Transactions value $
$14,650
Form type
4/A - Amendment
Date filed
8/24/2022, 09:00 PM
Date Of Original Report
Aug 1, 2022
Previous filing
May 25, 2022
Next filing
Aug 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MNKD Common Stock, $0.01 Par Value Award $14.7K +5K +0.64% $2.93 782K Jul 31, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 is being amended to correct the transaction code. The securities were purchased through the Company's Employee Stock Purchase Plan effective July 31, 2022.